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Abstract. 
 
Spatially controlled actin ﬁlament assembly 
is critical for numerous processes, including the vecto-
rial cell migration required for wound healing, cell-
mediated immunity, and embryogenesis. One protein 
implicated in the regulation of actin assembly is zyxin,
a protein concentrated at sites where the fast growing 
ends of actin ﬁlaments are enriched. To evaluate the 
role of zyxin in vivo, we developed a speciﬁc peptide in-
hibitor of zyxin function that blocks its interaction with 
 
a
 
-actinin and displaces it from its normal subcellular lo-
cation. Mislocalization of zyxin perturbs cell migration 
and spreading, and affects the behavior of the cell edge, 
a structure maintained by assembly of actin at sites 
proximal to the plasma membrane. These results sup-
port a role for zyxin in cell motility, and demonstrate 
that the correct positioning of zyxin within the cell is 
critical for its physiological function. Interestingly, the 
mislocalization of zyxin in the peptide-injected cells is 
accompanied by disturbances in the distribution of 
Ena/VASP family members, proteins that have a well-
established role in promoting actin assembly. In concert 
with previous work, our ﬁndings suggest that zyxin pro-
motes the spatially restricted assembly of protein com-
plexes necessary for cell motility.
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 cellular processes depend on cytoskeletal re-
arrangements involving actin filaments. For ex-
ample, cell locomotion and membrane exten-
sion appear to be largely driven by the spatially restricted
addition of actin monomers to free filament ends in the
lamellipodial leading edge (Small et al., 1978, 1995; Wang,
1985; Theriot and Mitchison, 1991). Moreover, cellular re-
sponses to extracellular signals often involve extensive re-
arrangement of the actin cytoskeleton, including localized
increases in actin polymerization (Zigmond, 1996; Chan
et al., 1998). Because so many important cell functions de-
pend on the actin cytoskeleton, it is important to under-
stand how the timing and spatial restriction of actin assem-
bly is achieved.
One protein that has been postulated to play a role in
the regulation of the actin cytoskeleton is zyxin (Beckerle,
1997). Zyxin displays a subcellular distribution that would
be compatible with such a function. In particular, zyxin has
been shown to colocalize with the actin cytoskeleton at
sites where the fast-growing ends of actin filaments are en-
riched, including lamellipodia and focal adhesions (Beck-
erle, 1986; Crawford and Beckerle, 1991). Moreover,
zyxin’s binding partner repertoire, which includes several
proteins with well-established roles in control of actin
function (Beckerle, 1997), suggests a role in cytoskeletal
regulation. Further evidence for the involvement of zyxin
in some aspect of actin assembly or organization comes
from studies in which zyxin has been targeted to the inner
face of the plasma membrane. Membrane-targeted zyxin
produces dramatic cytoskeletal rearrangements, including
loss of endogenous actin stress fibers and induction of ac-
tin-rich cell surface projections (Golsteyn et al., 1997).
These studies indicate that zyxin, in the proper subcellular
context, has the ability to direct cytoskeletal reorganiza-
tion.
Among zyxin’s notable structural features are an exten-
sive proline-rich NH
 
2
 
-terminal domain, a nuclear export
signal, and the presence of three COOH-terminal copies
of the LIM motif (Freyd et al., 1990; Sadler et al., 1992;
Macalma et al., 1996; Nix and Beckerle, 1997). The NH
 
2
 
-
terminal 381 amino acids of zyxin, including its proline-
rich region, has been shown to be sufficient to direct reor-
ganization of the actin cytoskeleton when targeted to the
plasma membrane (Golsteyn et al., 1997). In this region,
zyxin contains sequences that act as binding sites for mem-
bers of the Ena/VASP protein family (Niebuhr et al., 1997;
Purich and Southwick, 1997). Ena/VASP family members
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serve as ligands for the actin monomer binding partner,
profilin, and have themselves been shown to modulate ac-
tin assembly and/or organization (Gertler et al., 1996; Hut-
telmaier et al., 1999; Laurent et al., 1999). Interestingly,
the Ena/VASP binding sites present in zyxin are very simi-
lar to proline-rich repeats found in the ActA protein of
 
Listeria monocytogenes
 
, a bacterial species that infects
mammalian cells, and whose pathogenicity relies on its
ability to assemble actin filaments on its surface. The inter-
action of Ena/VASP proteins with 
 
Listeria
 
 ActA is essen-
tial for their recruitment to the site of actin assembly at the
bacterial surface (Chakraborty et al., 1995; Pistor et al.,
1995; Smith et al., 1996; Niebuhr et al., 1997). Thus, like
 
Listeria
 
 ActA, zyxin may act to dock members of the Ena/
VASP family at particular subcellular locations and may
facilitate spatially restricted changes in the actin cytoskele-
ton within eukaryotic cells.
Zyxin also interacts with 
 
a
 
-actinin (Crawford et al.,
1992), an actin binding and cross-linking protein that is en-
riched at the termini of stress fibers in focal adhesions,
which are sites of close membrane–substratum contact
(Maruyama and Ebashi, 1965; Lazarides and Burridge,
1975; Podlubnaya et al., 1975). Through its interaction
with the cytoplasmic domain of 
 
b
 
1 integrins (Otey et al.,
1990), 
 
a
 
-actinin is in a position to contribute to mem-
brane–cytoskeletal interactions by linking actin stress fi-
bers directly to the integrin transmembrane receptors. The
interaction of zyxin with 
 
a
 
-actinin has been proposed to be
important for zyxin localization and association with the
cytoskeleton (Crawford et al., 1992).
In this study, we have employed a custom peptide li-
brary to map the binding site of 
 
a
 
-actinin on zyxin, and
have used this information to design a synthetic peptide
inhibitor of this protein–protein interaction. We used this
peptide as a tool to further define the physiological role of
zyxin and the importance of its subcellular distribution by
introducing it into living cells and determining the effects
on cell behavior and morphology. Introduction of the pep-
tide inhibitor into cells causes the mislocalization of zyxin
and its binding partner, Mena, a mammalian member of
the Ena/VASP family. Zyxin displacement also results in
retraction of the cell edge and adversely affects cell
spreading and cell migration. Our results illustrate that
zyxin plays an important role in cell motility. We postulate
that zyxin functions in some aspect of cytoskeletal regula-
tion and microfilament dynamics, possibly by promoting
the assembly of protein complexes that stimulate actin po-
lymerization.
 
Materials and Methods
 
Synthetic Peptides
 
Peptides were synthesized with an NH
 
2
 
-terminal cysteine at the Univer-
sity of Utah core facility or by Genosys, Inc. Lyophilized peptides were re-
suspended in sterile PBS, and the pH was adjusted to 7.5 if necessary. The
sequence of the Zyx
 
16-30
 
 peptide is APAFYAPQKKFGPVV. The se-
quence of the scrambled peptide used as a control is VAFAKPY-
KQAVPGPF.
 
Protein Binding Studies
 
Binding studies with 
 
a
 
-actinin were performed using purified 
 
a
 
-actinin
from chicken smooth muscle (Feramisco and Burridge, 1980). The site of
 
a
 
-actinin binding on zyxin was determined using a custom-made peptide
library (SPOTs) conjugated to a cellulose membrane (Frank, 1992) and
was provided by Jurgen Wehland (Department of Cell Biology, Braun-
schweig, Germany). The library consisted of 187 overlapping peptides of
15 amino acids in length that spanned the complete human zyxin protein
sequence. Iodinated 
 
a
 
-actinin was used to probe the SPOTs membrane at
a concentration of 250,000 cpm/ml.
To evaluate the ability of the soluble Zyx
 
16-30 
 
peptide to block the
zyxin–
 
a
 
-actinin interaction, chicken zyxin was expressed in 
 
Escherichia
coli
 
 as a GST fusion protein
 
 
 
(Schmeichel and Beckerle, 1994). Lysates
were prepared from both uninduced bacterial cultures and cultures in-
duced to express GST-zyxin. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. After blocking, nitrocellulose strips were
overlaid with 5 
 
m
 
g/ml purified 
 
a
 
-actinin, or 
 
a
 
-actinin preincubated with
the Zyx
 
16-30 
 
peptide, or a control scrambled peptide. The strips were
washed in TBS and fixed briefly in 0.5% formaldehyde, followed by wash-
ing in 2.0% glycine. 
 
a
 
-Actinin binding to GST-zyxin was detected accord-
ing to standard immunoblot procedures using an mAb against 
 
a
 
-actinin
(Sigma Chemical Co.) and HRP-conjugated anti–mouse IgG (Amersham
Life Science) as a secondary antibody, followed by chemiluminescent de-
tection using enhanced chemiluminescence reagents (Amersham Life Sci-
ence).
To test the protein binding specificity of the Zyx
 
16-30
 
 peptide, the
peptide was coupled to HRP via the NH
 
2
 
-terminal cysteine residue using
EZ-Link™ maleimide-activated HRP (Pierce Chemical Co.). Proteins
present in a PtK2 cell lysate were separated by SDS-PAGE and trans-
ferred to nitrocellulose. 25 
 
m
 
g of coupled Zyx
 
16-30 
 
peptide was diluted in 5
ml TBS 
 
1 
 
0.1% Tween 20 and was incubated with the membrane. HRP-
Zyx
 
16-30 
 
peptide binding to protein on the blot was detected by using
chemiluminescence methods. The membrane was stripped and probed
with an mAb against 
 
a
 
-actinin, followed by incubation with HRP-conju-
gated anti–mouse IgG and chemiluminescent detection.
 
Microscopy
 
Video images were collected on a Leitz Fluovert inverted scope using a
Micromax CCD camera (Princeton Instruments) and analyzed using
Openlab image processing software (Improvision). Cells to be processed
for indirect immunofluorescence were allowed to recover at 37
 
8
 
C for 15
min after injection. Primary antibodies used for immunofluorescence were
the following: an antizyxin polyclonal (Macalma et al., 1996), an anti-
Mena polyclonal (Gertler et al., 1996), the antiphosphotyrosine mono-
clonal PY-20 (Transduction Laboratories), antivinculin, and anti–
 
a
 
-acti-
nin mAbs (Sigma Chemical Co.). Secondary antibodies used were Texas
red goat anti–rabbit IgG, FITC goat anti–rabbit IgG, and Texas red goat
anti–mouse IgG (Molecular Probes).
 
Microinjection Experiments
 
Potoroo tridactylis kidney (PtK2)
 
1
 
 cells were plated onto glass coverslips
18–36 h before microinjection. Cells were injected using an Eppendorf mi-
cromanipulator. In the experiments described here, peptides were in-
jected at a needle concentration of 0.6 mM–0.6 
 
m
 
M. These needle concen-
trations are above the threshold required for the maximal effect on cell
behavior. At a needle concentration of 0.06 
 
m
 
M, a smaller percentage of
cells displayed effects of the injected peptide. If cells were to be processed
for immunofluorescence, FITC-BSA was coinjected with peptides. For in-
jections in which the Zyx
 
16-30 
 
peptide was preincubated with 
 
a
 
-actinin, the
molar ratio of 
 
a
 
-actinin to peptide was 15:1. For myosin inhibition studies,
a fresh 0.5 M stock of diacetyl monoxime (ICN Laboratories) was pre-
pared in sterile H
 
2
 
O and added to cell medium for a final concentration of
10 mM. Quantitative data regarding the effects of peptide injection on
protein localization was obtained by visual observation of cells injected
and processed for immunofluorescence. In each case, over 100 cells were
injected and scored for localization of zyxin, Mena, or vinculin; analysis
was performed blind and in parallel by two independent investigators.
 
Cell Spreading Experiments
 
PtK2 epithelial cells were grown to 80–90% confluency. Cells were
trypsinized, washed, and resuspended in sterile PBS 
 
1
 
 10 mM MgCl at a
concentration of 2.5 
 
3
 
 10
 
6 
 
cells/ml. Peptide (400 
 
m
 
M) and a 3,000-D Texas
red dextran (0.1 mg/ml) were added to the cell suspension before elec-
troporation. An aliquot of cell suspension (0.5 ml) was placed in 2-mm gap
 
1. 
 
Abbreviation used in this paper: 
 
ptK2, Potoroo tridactylis kidney. 
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cuvettes and electroporated using an electrocell manipulator 600 (BTX
Inc.). Cells were incubated on ice for 15 min, washed, and plated onto fi-
bronectin (Sigma Chemical Co.) -coated coverslips. 3 h after plating, cells
were fixed and stained using FITC-phalloidin (Molecular Probes). After
electroporation, virtually all cells examined were observed to have taken
up this marker and, thus, can be assumed to have taken up peptide as well.
Two independent experiments were performed; between 150 and 200
measurements were taken for each population of cells. Cell area was de-
termined using NIH Image software, and statistical analysis was per-
formed using Instat software (GraphPad Software, Inc.). Cellular area
measurements of 
 
,
 
100 
 
m
 
m
 
2
 
 were not included in our calculations to elim-
inate the possibility of including data from nonviable cells in the analysis.
Data are reported as the mean area 
 
6
 
 SEM.
 
Cell Migration Experiments
 
Normal immortalized human mammary epithelial cells (184A) were cul-
tured in DFCI media containing 12.5 ng/ml EGF (Band and Sager, 1989).
Cells were plated onto 60-mm optically clear tissue culture dishes at a den-
sity of 2–4 
 
3 
 
10
 
5
 
 cells/ml 18–24 h before injection. Cells were injected with
the Zyx
 
16-30
 
 peptide and the control scrambled peptide using a needle con-
centration of 1.2 mM. Cell movement was recorded for a 3-h period after
injection using video microscopy. Migration distances were measured us-
ing Openlab imaging processing software (Improvision). Four separate
experiments were performed for each group of injections and measure-
ments were determined for 10–15 cells in each group. Statistical analysis
was performed using Instat software (GraphPad Software, Inc.). Data are
reported as the mean distance migrated per hour 
 
6 
 
SEM.
 
Results
 
a
 
-Actinin Interacts with Sequences in the NH
 
2
 
-terminal 
Region of Zyxin
 
Zyxin is concentrated at sites proximal to the plasma
membrane, including the focal adhesions and the lamelli-
podial leading edge, where the fast-growing ends of actin
filaments are clustered. To define further the physiological
role of zyxin, we sought to develop specific inhibitors of
zyxin function. Our initial effort has been directed toward
designing an inhibitor of the zyxin–
 
a
 
-actinin interaction
(Crawford et al., 1992). Zyxin and 
 
a
 
-actinin are exten-
sively colocalized in cells (Fig. 1) and we reasoned that in-
hibiting this interaction might perturb zyxin’s subcellular
distribution.
We precisely mapped the site of 
 
a
 
-actinin binding on
zyxin using a custom synthesized SPOTs peptide library
(Frank, 1992) that spanned the entire human zyxin se-
quence. Radiolabeled 
 
a
 
-actinin was used to probe this li-
brary and was found to interact most prominently with a
series of three peptides corresponding to sequences in
amino acids 13–33 of human zyxin (Fig. 2 A). Our deter-
mination of the 
 
a
 
-actinin binding site on zyxin using the li-
brary of zyxin-derived peptides refines the recently pub-
lished domain mapping performed by deletion analysis
(Reinhard et al., 1999). Quantitative analysis revealed that
the Zyx
 
16-30 
 
peptide (APAFYAPQKKFGPVV) inter-
acted most strongly with 
 
a
 
-actinin. Comparison of this re-
gion in human, mouse, and chicken zyxin shows that it is
highly conserved (Fig. 2 B). While other peptides in the li-
brary also interacted with 
 
a
 
-actinin, their relative strength
of binding was at least 50% less than that of the Zyx
 
16-30
 
peptide. For this reason, we focused on the testing of the
Zyx
 
16-30
 
 peptide as a possible inhibitor of the interaction of
zyxin with 
 
a
 
-actinin.
The ability of a synthetic Zyx
 
16-30
 
 peptide to compete
with zyxin for 
 
a
 
-actinin binding was tested. Chicken zyxin
was expressed as a GST fusion protein in bacteria (Fig. 3
A, lane 2). Proteins were transferred to nitrocellulose
and overlaid with purified 
 
a
 
-actinin (Fig. 3 A, lanes 3–8).
 
a
 
-Actinin interacted specifically with the zyxin fusion pro-
tein (Fig. 3 A, lane 4). The Zyx
 
16-30 
 
peptide was demon-
strated to block the interaction of 
 
a
 
-actinin with zyxin
Figure 1. Colocalization of zyxin and a-actinin in
PtK2 and IMR-90 cells by confocal microscopy.
a-Actinin (red) and zyxin (green) are colocalized
in focal adhesions (large arrow), along actin stress
fibers, and at the leading edge (small arrow).
Figure 2. Identification of the a-actinin binding site on zyxin. (A)
125I-labeled a-actinin was used to probe a library of zyxin-derived
peptides and was found to interact most prominently with three
adjacent peptides that correspond to amino acids 13–33 in the
NH2-terminal region of human zyxin (peptides A5, A6, and A7).
The sequences and alignment of these peptides are shown. (B) A
comparison of this region in human, mouse, and chicken zyxin
shows that it is highly conserved. 
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(Fig. 3 A, lane 6), whereas a scrambled peptide with an
identical amino acid composition did not (Fig. 3 A, lane 8).
This experiment demonstrated the ability of the Zyx
 
16-30
 
peptide to act as an inhibitor of the zyxin–
 
a
 
-actinin inter-
action.
To test the specificity of the peptide for binding to 
 
a
 
-acti-
nin, we used the Zyx
 
16-30
 
 peptide to probe the complex
mixture of proteins present in a PtK2 cell lysate (Fig. 3 B,
lane 1). PtK2-derived proteins were electrophoretically re-
solved and transferred to nitrocellulose and were probed
with HRP-conjugated Zyx
 
16-30
 
 peptide. The Zyx
 
16-30
 
 pep-
tide interacted specifically with a protein that migrated at
an apparent molecular mass of 100,000 D (Fig. 3 B, lane
2). To confirm the identity of this protein as 
 
a
 
-actinin, the
membrane was stripped and probed with an mAb directed
against 
 
a
 
-actinin, which recognized the same protein pro-
file as that bound by the zyxin-derived peptide (Fig. 3 B,
lane 3). These studies indicated that the Zyx
 
16-30
 
 peptide is
likely to be a useful reagent for examining the importance
of zyxin’s interaction with 
 
a
 
-actinin in vivo and for further
dissection of zyxin function.
 
The Zyx
 
16-30
 
 Peptide Causes Mislocalization of Zyxin
In Vivo
 
Once we had established the effectiveness and specificity
of the Zyx
 
16-30
 
 peptide reagent as an inhibitor of the inter-
action of zyxin with 
 
a
 
-actinin in vitro, we examined the ef-
fect of intracellular peptide on zyxin’s subcellular distribu-
tion. For these studies, we used PtK2 cells, an epithelial
cell line derived from rat kangaroo. This cell type has been
used in several previous studies of cytoskeletal processes,
including cell spreading and myosin-dependent activities
(Sanger, 1975; Sanger et al., 1984, 1989; Cramer and
Mitchison, 1995, 1997). It has been shown recently that the
initial sites of actin assembly in PtK2 cells are the borders
of lamellipodia and the focal adhesions (Turnacioglu et al.,
1998), which were sites where 
 
a
 
-actinin is enriched and
where zyxin is also found. In addition, cells of this type are
especially amenable to microinjection and the localization
of cytoskeletal proteins by indirect immunofluorescence.
In PtK2 cells injected with the Zyx
 
16-30 
 
peptide, zyxin is
substantially mislocalized; the protein is no longer concen-
trated in focal adhesions or at cell borders (Fig. 4 A, an as-
Figure 3. Characterization of the effectiveness and specificity of
the zyxin-derived peptide as an inhibitor of the zyxin–a-actinin
interaction. (A) A peptide corresponding to the site of a-actinin
interaction with zyxin inhibits the interaction of zyxin and a-acti-
nin in vitro. a-Actinin binding to a GST-zyxin fusion protein was
tested using a blot overlay with purified a-actinin. Lanes 1, 3, 5,
and 7 contain uninduced bacterial cell lysate; lanes 2, 4, 6, and 8
contain lysates from cells in which expression of the GST-zyxin
fusion was induced. a-Actinin binds to GST-zyxin in the blot
overlay (lane 4). In the presence of the Zyx16-30 peptide, binding
of a-actinin to GST-zyxin is inhibited (lane 6). Addition of a
scrambled peptide with identical amino acid composition had no
effect on the interaction (lane 8). (B) The HRP-coupled Zyx16-30
peptide interacts specifically with a-actinin. Lane 1 shows a Coo-
massie-stained gel of proteins present in a PtK2 cell lysate. HRP-
conjugated Zyx16-30 peptide interacts specifically with a-actinin
(lane 2). Lane 3 shows the same membrane after stripping and
probing with an anti–a-actinin mAb.
Figure 4. Injection of the Zyx16-30 peptide causes mislocalization
of zyxin and its binding partner Mena. Cells were injected with a
fluorescent marker, and peptides were subsequently fixed and
prepared for indirect immunofluorescence with specific antibod-
ies. FITC-BSA was used as a marker for identification of injected
cells, which are indicated by the asterisks. Injection of the Zyx16-30
peptide results in mislocalization of zyxin (A). Injection of a
scrambled version of the peptide does not result in zyxin mislo-
calization (B). Vinculin is still localized normally in cells injected
with the Zyx16-30 peptide, indicating that focal adhesion structure
is still intact (C). a-Actinin remains associated with actin mi-
crofilaments that appear intact, albeit somewhat reorganized, in
the peptide-injected cells. However, many retraction fibers are
evident and linear aggregates of filaments are found parallel to
the cell periphery (D). Interestingly, mislocalization of zyxin is
accompanied by a significant depletion of zyxin’s binding part-
ner, Mena, from focal adhesions (E). Phosphotyrosine-contain-
ing proteins remain enriched in focal adhesion structures, al-
though there is a reproducible reduction in signal intensity
compared with neighboring, uninjected cells (F). 
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terisk marks the injected cell which was identified by the
presence of a fluorescent marker that was introduced with
the peptide). In contrast, injection of a scrambled peptide
with identical amino acid composition did not adversely
affect zyxin localization (Fig. 4 B). Although zyxin was
substantially displaced from its normal subcellular loca-
tion by the introduction of the Zyx16-30 peptide, the struc-
tural integrity of the focal adhesions is retained. Injection
of the Zyx16-30 peptide did not alter the distribution of an-
other focal adhesion constituent, vinculin (Fig. 4 C), and
focal adhesions could still be visualized using interference
reflection contrast microscopy (data not shown). Thus, ap-
propriate subcellular localization of zyxin does not appear
to be essential for the short-term maintenance of preexist-
ing focal adhesions. In addition, actin-rich stress fibers re-
main assembled in injected cells (data not shown) and
a-actinin exhibits its normal periodic distribution along
stress fibers (Fig. 4 D). However, as will be discussed in
greater detail below, actin-rich retraction fibers and dense
bundles of actin filaments that run parallel to the cell edge
are evident at the borders of cells that have been injected
with the zyxin-derived peptide, illustrating that distur-
bance of the zyxin–a-actinin interaction has some adverse
effects on cell morphology and cytoskeletal organization
(Fig. 4 D).
Interestingly, mislocalization of zyxin is accompanied by
a striking depletion of the zyxin binding partner, Mena, a
member of the Ena/VASP family from its normal subcel-
lular locations (Fig. 4 E). In particular, we noted a reduc-
tion in the accumulation of Mena and VASP in focal adhe-
sions with a concomitant increase in cytoplasmic labeling
of the peptide-injected cells. In addition to the loss of
Mena, mislocalization of zyxin results in a noticeable re-
duction in the phosphotyrosine content of the focal adhe-
sion (Fig. 4 F). Although antigen levels cannot be reliably
quantified by immunocytochemical methods, the apparent
reduction in phosphotyrosine content in the focal adhe-
sions of the peptide-injected cells may reflect a loss of
Ena/VASP family members from these sites since these
proteins are known to be tyrosine phosphorylated (Gert-
ler et al., 1996; Comer et al., 1998).
In an effort to define more quantitatively the effect of
peptide injection on the protein composition of focal ad-
hesions, cells were injected with either the Zyx16-30 peptide
or the control scrambled peptide, and scored for correct
localization of zyxin, Mena, and vinculin (Table I). For
each focal adhesion component considered, a minimum of
200 cells was injected and scored for protein localization
by immunofluorescence. In cells injected with the scram-
bled peptide, less than a quarter of the cells (from 8 to
24%, depending on the protein evaluated) displayed any
noticeable alteration in the normal subcellular distribu-
tions of zyxin, Mena, or vinculin. In contrast, the majority
of cells injected with the Zyx16-30 peptide showed mislocal-
ization of zyxin and Mena; in both cases z70% of the cells
displayed a clear loss of these proteins from the focal ad-
hesions. At a minimum, these results illustrate that injec-
tion of the Zyx16-30 peptide causes the concurrent mislocal-
ization of zyxin and Mena in z40% of the cells examined.
Only 25% of cells injected with the Zyx16-30 peptide
showed mislocalized or reduced vinculin at the focal adhe-
sion; this level is similar to what we observed for the con-
trol peptide. Our observation that vinculin remains largely
concentrated in the focal adhesion after peptide injection
also indicates that the loss of zyxin and Mena is unlikely to
be a result of nonspecific disruption of focal adhesion
structures.
Introduction of the Zyx16-30 Peptide into PtK2 Cells 
Affects the Position of the Cell Edge
If zyxin plays a role in actin dynamics, focal adhesion as-
sembly, or cell adhesion, mislocalization of zyxin in living
cells could be expected to alter cell morphology and be-
havior. We examined the effect of zyxin mislocalization on
cell behavior at a higher resolution by microinjection of
the Zyx16-30 peptide into PtK2 cells and monitoring the cel-
lular response in real time using video microscopy. Intro-
duction of the Zyx16-30 peptide into cells produced a rapid
retraction of the cell edge (Fig. 5, panel 1). A quantitative
view of the results from these experiments, illustrating the
dynamic behavior of the cell edge for several representa-
tive cells is shown in Fig. 6. The average rate of rearward
displacement for cells injected with the Zyx16-30 peptide
was 2.7 microns/min during the 5-min observation period.
Numerous retraction fibers were evident at the borders of
these injected cells. Injection of cells with buffer solutions
alone or with solutions containing BSA or a-actinin did
not produce this response, indicating that it is not a result
of the microinjection technique (data not shown). In addi-
tion, injection of a scrambled version of the peptide had no
effect on cell morphology (Fig. 5, panel 2, and Fig. 6), and
preincubation of the Zyx16-30 peptide with a-actinin before
microinjection inhibited the effects of the bioactive pep-
tide (Fig. 5, panel 3, and Fig. 6). Table II shows the results
of several microinjection experiments in which cells were
observed for several minutes after microinjection and
scored for response. Nearly 90% of cells injected with the
Zyx16-30 peptide exhibited retraction of the cell edge after
microinjection, whereas ,12% of the cells injected with
control solutions displayed any evidence of retraction. The
observation that the percentage of cells exhibiting edge re-
traction is apparently greater than the percentage of cells
showing mislocalization of zyxin (compare Tables I and II)
may be a reflection of the relatively stringent criteria we
used to define loss of zyxin localization by immunofluores-
cence; some cells that we scored as lacking a disturbance in
zyxin localization in response to peptide injection may in-
deed have sustained a disturbance in zyxin distribution
sufficient to produce cell retraction, but insufficient for us
to score it as mislocalized.
Table I. Effect of Peptide Injection on Localization of Adhesion 
Plaque Proteins
Adhesion plaque
component Injected peptide
Percentage of cells showing
mislocalized protein*
Zyxin Zyx16-30 67%
Scrambled 8%
Mena Zyx16-30 72%
Scrambled 24%
Vinculin Zyx16-30 25%
Scrambled 19%
*At least 200 cells were injected and scored in each category.The Journal of Cell Biology, Volume 147, 1999 1554
Cell shape is controlled in part by the balance between
the opposing activities of actin assembly, which drives
membrane protrusion, and myosin-powered retrograde
movement, which causes retraction (Theriot and Mitchi-
son, 1991; for review see Welch et al., 1997). For example,
in certain neuronal growth cones, an inverse relationship
between actin-assembly driven membrane extension and
myosin-powered retraction has been precisely character-
ized (Lin et al., 1996). To determine whether the retrac-
tion of the cell edge that we observed was dependent on
myosin activity, PtK2 cells were injected with Zyx16-30 pep-
tide in the presence of diacetyl monoxime, an inhibitor of
nonmuscle myosins (Cramer and Mitchison, 1995). Myo-
sin inhibition was found to prevent retraction of the cell
edge in response to microinjection (Fig. 5, panel 4, and
Fig. 6).
The Zyx16-30 Peptide Inhibits Cell Spreading
on Fibronectin
An attractive model for zyxin function is that of a molecu-
lar scaffold that functions to promote site-specific actin as-
sembly. This hypothesis is consistent with zyxin’s ability to
promote assembly of actin-rich structures when targeted
to the plasma membrane (Golsteyn et al., 1997), as well as
its interaction with proteins known to be involved in cy-
toskeletal regulation (Beckerle, 1997). If zyxin plays a role
in the spatial control of actin assembly, mislocalization of
zyxin might be expected to affect processes that are de-
pendent on localized actin assembly, such as cell spreading
and cell migration. To explore the effect of zyxin mislocal-
ization on these processes, we first examined the effect of
peptide-dependent displacement of zyxin on the rate of
cell spreading.
In parallel experiments, the Zyx16-30 peptide or a scram-
bled peptide of identical amino acid composition was in-
troduced into PtK2 cells in suspension via electroporation.
Texas red dextran was simultaneously introduced as a
marker for successful electroporation; virtually all cells ex-
amined were observed to have taken up this marker (data
not shown) and, thus, can be assumed to have internalized
peptide as well. After electroporation, cells were plated
onto fibronectin-coated coverslips (Bereiter-Hahn et al.,
1990; Mooney et al., 1995), and allowed to spread for 3 h
before fixation and staining with FITC-phalloidin. Cell ar-
eas were determined for 150–200 cells per experimental
condition. Cells into which the scrambled peptide was in-
troduced were well spread within 3 h after plating (Fig. 7
A) and achieved an average area of nearly 417 mm2. In
contrast, cells into which the Zyx16-30 peptide was intro-
Figure 5. Injection of the Zyx16-30 pep-
tide induces lamellipodial retraction.
Small arrows show the original position
of the cell edge before injection. For
the cell shown in the figure, the cell
margin retracted by 12 microns during
the 5-min interval after microinjection
of the Zyx16-30 peptide (panel 1). A
lamellipodial extension that retracted
rapidly after injection of the Zyx16-30
peptide is highlighted (large arrow),
and numerous retraction fibers are evi-
dent at the cell border. Injection of a
scrambled peptide does not produce
this effect (panel 2). Preincubation of
the Zyx16-30 peptide with a-actinin be-
fore injection blocks the ability of the
peptide to induce this response (panel
3). In the presence of the myosin inhibi-
tor diacetyl monoxime, retraction of the
cell edge fails to occur upon injection of
the zyxin-derived peptide (panel 4).
Table II. Effect of Peptide Injection on Position of the
Cell Edge
Needle contents No. cells injected
Percentage of cells in 
which retraction of the 
cell edge was observed
Zyx16-30 peptide 80 89%
Scrambled peptide 60 5%
a-Actinin 1 Zyx16-30 peptide 65 9%
0.5 mg/ml FITC-BSA 66 12%Drees et al. Zyxin Function in Cell Motility 1555
duced exhibited an average area of only 235 mm2. The av-
erage cell area was reduced by nearly 44% for cells har-
boring the inhibitory Zyx16-30 peptide relative to cells
harboring the scrambled peptide (Fig. 7 C).
Injection of the Zyx16-30 Peptide Inhibits Cell Migration
To explore further the role of zyxin in cell motility, we ex-
amined the effect of introducing the Zyx16-30 peptide into a
highly migratory cell type. We used 184A cells, immortal-
ized normal mammary epithelial cells (Band and Sager,
1989), which exhibit an increased rate of cell migration in
response to EGF (Matthay et al., 1993). Immunoblot anal-
ysis confirmed that zyxin is expressed in this cell type (Fig.
8 A). Indirect immunofluorescence reveals that zyxin is
present in the cytoplasm as well as the leading edges of
these highly motile cells (Fig. 8 B). Either the Zyx16-30 pep-
tide or the control scrambled peptide was introduced into
individual cells via microinjection. After microinjection,
cellular movements were recorded and measured over a 3-h
observation period using time-lapse video microscopy.
Cells into which the Zyx16-30 peptide was injected (Fig. 9,
A–C) showed a significantly decreased rate of migration
relative to cells injected with the scrambled peptide (Fig.
9, D–F). The average rate of migration for the control cells
was 46 mm/h, whereas cells injected with the Zyx16-30 pep-
tide traveled at a rate of 23 mm/h, a 50% reduction in mo-
tility (Fig. 9 G). No statistically significant difference in the
rate of migration was observed in cells injected with the
scrambled peptide when compared with uninjected cells
(data not shown).
Discussion
Zyxin was discovered as a component of focal adhesions
.10 yr ago, however, its physiological role has remained
relatively obscure. An important insight into the possible
function of zyxin within cells came with the recognition of
Figure 6. Quantitative analysis of cell behavior after injection of
the Zyx16-30 peptide. The change in position of the cell edge rela-
tive to its original position before injection is shown for represen-
tative individual cells injected with the Zyx16-30 peptide (closed
squares), the scrambled version of the peptide (open squares),
Zyx16-30 peptide preincubated with a-actinin (triangles), and cells
injected with the Zyx16-30 peptide in the presence of 10 mM di-
acetyl monoxime (open circles). The average rate of cell edge re-
traction upon injection of the Zyx16-30 peptide was determined to
be 2.7 microns/min.
Figure 7. The Zyx16-30 peptide inhibits cell spreading. Pep-
tides were introduced into cells in suspension via electropo-
ration. Cells were fixed and stained with FITC-phalloidin 3 h
after plating onto fibronectin-coated coverslips, and the aver-
age cell area was determined. Compared with cells into
which scrambled peptides were introduced (A), cells elec-
troporated in the presence of the Zyx16-30 peptides (B)
showed a reduction in mean cell area of 43.5% (C). Data are
reported as the mean area 6 SEM.
Figure 8. Zyxin is present in 184A normal immortalized mam-
mary epithelial cells. (A) Proteins present in a 184A cell lysate
were transferred to nitrocellulose and probed with antizyxin
polyclonal antisera (lane 1) and preimmune sera (lane 2). A pro-
tein of apparent molecular mass of 82 kD is recognized by the an-
tizyxin antisera. (B) Indirect immunofluorescence localization of
zyxin in 184A cells shows that zyxin is enriched in the leading
edge of these motile cells.The Journal of Cell Biology, Volume 147, 1999 1556
the relationship between zyxin and the ActA protein of
Listeria monocytogenes (Reinhard et al., 1995; Golsteyn
et al., 1997). Both zyxin and ActA display proline repeats
capable of docking members of the Ena/VASP family
(Pistor et al., 1995; Niebuhr et al., 1997). In the case of
Listeria, the association of Ena/VASP proteins with ActA
present on the bacterial surface is clearly important for the
organization of the actin comet tail and for the motility of
the bacterium (Smith et al., 1996; Laurent et al., 1999).
The demonstration that zyxin and ActA share the capacity
to bind Ena/VASP proteins led to the suggestion that
zyxin may represent an important regulator of actin arrays
within eukaryotic cells. This notion gained some support
when it was shown that zyxin induces the elaboration of
actin-rich cell surface extensions when the protein is tar-
geted to the inner leaflet of the plasma membrane by the
presence of a COOH-terminal CAAX sequence (Gol-
steyn et al., 1997).
Here, we have endeavored to test further the role of
zyxin within living cells. Since the appropriate subcellular
localization of a protein is often critical to its function, we
reasoned that if we could develop a peptide inhibitor that
interfered with the normal subcellular distribution of zyxin
in living cells, the behavior of the cells might clarify the
physiological role of zyxin, and/or protein complexes that
depend on zyxin. The interaction of zyxin with a-actinin
has been proposed to be important for zyxin’s association
with the cytoskeleton (Crawford et al., 1992). We have fo-
cused on characterization of this interaction in our efforts
to further define the physiological role of zyxin and ex-
plore the functional significance of zyxin’s subcellular dis-
tribution.
In this study, we have mapped the region of zyxin that
interacts with a-actinin to a region in the extreme NH2
terminus of zyxin, to amino acids 16–30, and have used
this information to design a peptide inhibitor of this pro-
tein–protein interaction. In cells injected with the Zyx16-30
peptide, zyxin is substantially mislocalized. This mislocal-
ization of zyxin is correlated with a disturbance in the dis-
tribution of the zyxin binding partner, Mena. The ability
of Ena/VASP family members to interact with vinculin
(Brindle et al., 1996; Reinhard et al., 1996) may account
for the retention of a residual amount of Mena often de-
tected in focal adhesions or may reflect incomplete dis-
placement of zyxin by the peptide competitor. In either
case, our results support a model in which the normal sub-
cellular localization of Mena depends to a large extent on
its interaction with zyxin.
The mechanism by which the Zyx16-30 peptide interferes
with the normal subcellular localization of zyxin is not
completely clear. A simple interpretation would be that
zyxin’s interaction with a-actinin is important for its sub-
cellular distribution. Although this may indeed be the
case, our preliminary results demonstrate that the LIM re-
gions of zyxin are sufficient to target zyxin to the focal ad-
hesions (Nix, D., S. Bockholt, and M.C. Beckerle, unpub-
lished observations). Also, although zyxin and a-actinin
are substantially colocalized, the presence of a-actinin
alone cannot be sufficient to cause the recruitment of
zyxin to specific cellular locations, since there are situa-
tions in which a-actinin occurs in sites that lack zyxin.
Therefore, in our microinjection experiments, it appears
likely that the presence of the Zyx16-30 peptide introduces
some steric interference that is incompatible with the pres-
ence of full-length zyxin.
Introduction of the Zyx16-30 peptide into cells produced
a clear and statistically significant decrease in the rate of
cell spreading on fibronectin and in the rate of cell migra-
tion in a motile cell type. In addition, our results suggest
that zyxin plays a role in maintenance of the integrity and
position of the cell border. For example, in PtK2 cells, mis-
localization of zyxin produces a retraction of the cell edge
that is dependent on a myosin motor activity. Such effects
on cell behavior would be expected if zyxin contributed to
Figure 9. Injection of the Zyx16-30
peptide into 184A cells has an ad-
verse effect on the rate of cell mi-
gration. Cells were injected with the
Zyx16-30 peptide (A–C) or the con-
trol peptide (D–F). Cells are shown
immediately after injection (A and
D) at their initial positions (1 and 2)
and 3 h after injection (B and E) at
their final positions (19 and 29).
Comparison of the path of migra-
tion for injected cells over the 3-h
period (C and F) shows that cells
injected with the Zyx16-30 peptide
have substantially reduced motility
compared with control cells. The
difference in mean migration rates
for cells injected with the Zyx16-30
peptide compared with cells in-
jected with the scrambled peptide is
shown in G; a minimum of 10 cells
was analyzed for each condition.
Data are reported as the mean dis-
tance migrated per hour 6 SEM.Drees et al. Zyxin Function in Cell Motility 1557
lamellipodial integrity or function. Alternatively, although
some focal adhesion components, such as vinculin, still ap-
pear to be localized appropriately after microinjection of
the zyxin-derived peptide, the cell behavior we observe
could result from a decrease in cell adhesiveness because
of partial dissolution of established focal adhesions or per-
turbation of nascent adhesion sites. Additional investiga-
tion will be required to evaluate whether the effects of
zyxin mislocalization on cell motility results from distur-
bances in the function of the leading edge, substratum ad-
hesion machineries, or both. In either case, it is intriguing
to consider the possibility that a primary consequence of
the mislocalization of zyxin is a reduction of localized actin
polymerizing activity. Consistent with this view, it is clear
that in PtK2 cells, the sites where monomeric actin is being
most rapidly incorporated into existing filaments are at the
focal adhesions and the edges of lamellipodia, sites where
zyxin is normally detected (Fig. 1; Turnacioglu et al.,
1998). Furthermore, as will be discussed in greater detail
below, the now well-established relationship between
zyxin and the ActA protein of Listeria suggests a role for
zyxin in actin assembly dynamics in vivo.
Several lines of evidence illustrate the specificity and ef-
fectiveness of the Zyx16-30 peptide as an inhibitor of zyxin
function. Biochemical tests have illustrated the ability of
the zyxin-derived peptide to compete for zyxin docking
sites on a-actinin, and have shown that a-actinin is the sole
ligand for the peptide that is detected in cell lysates. The
displacement of zyxin that we observe in living cells that
have been injected with the zyxin-derived peptide suggests
that this peptide can dock on a-actinin in vivo and prohibit
simultaneous binding of endogenous zyxin to these sites.
The fact that a-actinin retains its ability to associate with
filamentous actin in cells injected with the zyxin-derived
peptide, at least as evaluated by immunocytochemical
methods, illustrates that the binding of the Zyx16-30 peptide
to the globular head domain of a-actinin does not cause a
global disturbance of a-actinin function in vivo. Thus, the
zyxin-derived peptide appears to be exerting a relatively
localized effect on the a-actinin globular head domain that
serves as a docking site for zyxin (Crawford et al., 1992).
To demonstrate unequivocally that the effects observed
with the zyxin-derived peptide are due exclusively to ef-
fects on zyxin, rather than a disturbance of a-actinin func-
tion, it would be necessary to perform complementary
peptide competition experiments in which a peptide corre-
sponding to the zyxin binding site on a-actinin was em-
ployed. Unfortunately, these experiments are not possible
since the zyxin binding site on a-actinin does not map to a
discrete collection of contiguous amino acids (data not
shown). However, further support that the peptide effects
on motility are specifically due to effects on zyxin comes
from the use of an alternative approach to probe zyxin
function in vivo. Inhibition of zyxin function by chroma-
phore-assisted laser inactivation also perturbs cell spread-
ing and migration, which is consistent with the results re-
ported here (Benson, B., F. Wang, D.G. Jay, and M.C.
Berkerle, manuscript submitted for publication).
The evidence that zyxin is important for optimal cell
motility is particularly interesting in light of the relation-
ship established between zyxin and the ActA protein of L.
monocytogenes (Golsteyn et al., 1997; Niebuhr et al.,
1997).  Listeria has long been a favorite model system for
understanding the mechanisms that drive actin-based mo-
tility, including the manner in which actin assembly sites
are specified. Rapid addition of actin monomers to free fil-
ament ends enriched at the bacterial cell surface provides
the force that powers bacterial motility (Tilney and Port-
noy, 1989; Tilney et al., 1992; Sanger et al., 1992; Theriot
et al., 1992). In a similar manner, the free ends of actin fil-
aments are concentrated at the leading edge of lamellipo-
dia, and filament elongation appears to be the driving
force behind membrane protrusion (Small et al., 1978,
1995; Wang, 1985). Our results are consistent with the
view that the physiological role of zyxin is somewhat anal-
ogous to that of the Listeria ActA protein, in particular
with the idea that zyxin contributes to the specification of
actin assembly zones. In this regard, it is interesting that
zyxin was recently identified as one of the proteins that is
recruited to sites of cdc42-induced actin polymerization
(Castellano et al., 1999).
The precise mechanism by which zyxin enhances cell
motility is not clarified by our studies. However, an attrac-
tive model for zyxin function is that of a molecular scaf-
fold, which functions to facilitate the formation of a molec-
ular complex that promotes site-specific actin assembly.
This view is consistent with zyxin’s ability to interact with
several proteins known to be involved in cytoskeletal reg-
ulation (Beckerle, 1997) as well as its ability to promote
the assembly of actin-rich structures when targeted to the
plasma membrane (Golsteyn et al., 1997). Our results sug-
gest that zyxin plays a significant role in the targeting of
Ena/VASP family members to specific regions of the cell.
This conclusion is consistent with genetic studies showing
that lethal point mutations in the Drosophila ena (en-
abled) gene display both loss of ability to bind zyxin and
Figure 10. A model for zyxin function. We postulate that zyxin
functions as a molecular scaffold to facilitate the assembly of a
multiprotein complex that promotes actin assembly at specific
sites within the cell, including the lamellipodial leading edge (A).
The position of the leading edge is in part the result of a balance
between the rate of actin polymerization and the rate of myosin-
powered retrograde flow of actin filaments. According to this
model, induction of zyxin mislocalization using a specific peptide
inhibitor (B) results in a loss or reduction of actin polymerizing
activity in the leading edge. Myosin-powered retrograde flow be-
comes the dominant force affecting the actin filament, resulting
in retraction of the cell edge. Because the NH2-terminal region of
zyxin has been shown to be sufficient for its ability to promote ac-
tin assembly at the plasma membrane (Golsteyn et al., 1997), we
have focused on binding partner interactions known to occur in
this area of the protein. (M/V, Mena/VASP; P, profilin).The Journal of Cell Biology, Volume 147, 1999 1558
loss of ability to localize properly within cells (Ahern-Dja-
mali et al., 1998). The interaction of Ena/VASP family
members with the Listeria ActA protein appears to be cru-
cial for producing the high rate of actin assembly required
for optimal bacterial motility (Smith et al., 1996; Laurent
et al., 1999). By analogy, an important feature of zyxin
function may be to provide localized docking sites for Ena/
VASP family members at sites destined for actin assembly
within the eukaryotic cytoplasm (Fig. 10). It is also likely
that other zyxin binding partners, both known and as yet
unidentified, participate in motile cell processes.
In conclusion, our efforts to probe the physiological role
of zyxin demonstrate that the activity and positioning of
zyxin is important in actin-dependent processes, including
cell migration and cell spreading. Cell movement is a com-
plex process that requires extensive cytoskeletal rear-
rangements, including spatially controlled actin assembly.
This process clearly requires many participants, including
nucleating factors, proteins that regulate the availability of
filament ends, and proteins that facilitate filament elonga-
tion. We speculate that zyxin facilitates the recruitment of
actin assembly machinery to specific subcellular domains,
and that the concentration of zyxin and its partners at
these sites is important for creation of a cytoplasmic zone
that supports accelerated actin assembly.
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